Should I be on hormone therapy for my bones — and why did my doctor seem so cautious about it?
Here's the point
Whether hormone therapy is right for your bones is a decision only you and your prescriber can make, based on your personal history — but it's worth knowing the evidence on hormones and bone is actually strong and has often been misrepresented, which is likely why your doctor is being careful. The caution usually traces back to one 2002 trial that was widely misreported; since then, the understanding has shifted considerably, especially around a woman's age and timing when therapy starts.
Your doctor's caution likely traces back to the Women's Health Initiative, a large 2002 trial that was stopped early and reported as proof that hormone therapy causes breast cancer and heart disease. Prescribing dropped sharply worldwide afterward. But the trial's actual findings were more nuanced: the breast cancer increase was small in absolute terms, the oestrogen-only arm (for women without a uterus) showed no increase, and the one unambiguous result — never disputed — was that hormone therapy significantly reduced fractures, including hip fractures.
What changed the conversation since is what's called the timing hypothesis, now reflected in major menopause society guidance. For women who start therapy under 60 or within about ten years of menopause, without specific contraindications, the evidence balance is generally favourable for symptoms and bone, without excess cardiovascular harm in that group. Starting much later, especially with existing arterial disease, looks different — which is where much of the original cardiovascular concern came from. Route of delivery and progestogen type also appear to matter.
It helps to understand why bone is affected at all: oestrogen normally restrains the cells that break down bone, and when it falls at menopause, bone loss accelerates — often fastest in the early transition. This is also why some groups are considered higher-risk and worth flagging specifically, including premature menopause, androgen deprivation therapy for prostate cancer, and aromatase inhibitor therapy for breast cancer, where bone loss can be rapid and is often unmanaged.
Two honest limits worth knowing: bone benefits from hormone therapy generally fade after stopping, so it's a condition you maintain rather than a one-time fix. And hormones create a permissive environment for bone — they don't supply the mechanical signal that tells bone where to build. That's a separate, ongoing part of your bone strategy, regardless of what you and your prescriber decide about hormones.
Know these words
Hormone replacement therapy (HRT) replaces oestrogen, often with a progestin, after menopause and has been shown to…
The Women's Health Initiative, or WHI, was a major 2002 study on hormone therapy in postmenopausal women that found…
The timing hypothesis is the idea that when a woman starts hormone therapy, relative to her menopause, strongly…
Menopause is when your periods stop and estrogen levels drop sharply, which speeds up bone loss because the cells…
Estrogen is a hormone that protects bone by keeping bone-removing cells in check. Falling estrogen, especially at…
Bioidentical (or body-identical) hormones are hormones that are structurally identical to the ones your own body…
How sure is this?
Graded Strong Clinical Evidence: Supported by multiple well-designed clinical studies in humans. Read each study with its grade in mind. One study is a piece of the picture, not the whole of it.
The lessons behind this answer
More on medications and hormones
Bone medications generally work in one of two ways: they either slow down the cells that break down old bone (antiresorptives), or they actively stimulate the cells that build new bone (anabolics). Which family your drug belongs to tells you a lot about what it can realistically do, and that's worth asking your prescriber about directly.
Read the full answer →That's a decision for you and your prescriber, not something OsteoStrong changes. Medication and mechanical loading work on different parts of the same system — your drug manages the chemical signalling of bone remodeling, while loading supplies a mechanical stimulus along with muscle, balance and coordination. They're meant to work alongside each other, not replace one another.
Read the full answer →Stopping Prolia (denosumab) isn't a neutral event. Because it doesn't build up in your bones the way bisphosphonates do, its protective effect wears off once doses stop. This can lead to a rapid rebound in bone turnover and a risk of multiple vertebral fractures, sometimes within months — so this is a decision to make with your prescriber, not on your own.
Read the full answer →Yes, it's possible — a number of common medications can affect bone, so it's a smart question to ask. This doesn't mean you should change anything on your own; it just means it's worth reviewing your full medication list with your prescriber to understand whether bone monitoring makes sense for you.
Read the full answer →Have a question that isn't here? Ask us at your next visit, or ask our AI bone health advisor.
Education only, not medical advice. Decisions about tests, medications and treatment belong with your own doctor. OsteoStrong does not diagnose, treat or cure any disease.
